Trista Morrison

Investor Relations Contact at VOYAGER THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Trista Morrison is currently Director at Network of Tyrosinemia Advocates, Inc. and Chief of Staff & Chief Corporate Affairs Officer at Voyager Therapeutics, Inc. Former roles include Director-Corporate Communications at Ironwood Pharmaceuticals, Inc., Head-Media Relations at Gemin X Pharmaceuticals US, Inc., and Chief Communications Officer at Saniona AB. Education includes an undergraduate degree from Tulane University (Louisiana).

Trista Morrison active positions

Companies	Position	Start
VOYAGER THERAPEUTICS, INC.	Investor Relations Contact	18/09/2022
Network of Tyrosinemia Advocates, Inc.	Director/Board Member	-

All active positions of Trista Morrison

Former positions of Trista Morrison

Companies	Position	End
IRONWOOD PHARMACEUTICALS, INC.	Public Communications Contact	-
SANA AB	Public Communications Contact	-
Gemin X Pharmaceuticals US, Inc. Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products	Public Communications Contact	-

See the detail of Trista Morrison's experience

Training of Trista Morrison

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Trista Morrison's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Ironwood Pharmaceuticals, Inc. Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products	Health Technology
Tulane University (Louisiana) Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gemin X Pharmaceuticals US, Inc. Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products	Health Technology
Voyager Therapeutics, Inc. Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system	Health Technology
Saniona AB Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases	Health Technology
Network of Tyrosinemia Advocates, Inc.